RE:RE:RE:Note from the portfolio managerHatrik, gibbonsj, me thinks you two gents are being too conservative. Now that being said, it's a tough call really, depending on what camp you are in. It looks like we are heading into a reccession, some would argue we are already there. Short term, longterm, hard landing, soft landing, who the hell knows, even the so called experts are all over the map.
Healthcare stocks should be defensive against the R word, but likely not unscathed and it will effect the markets and investors mindset regardless. At the end of the day we have no control, any reccession will play out as it does. Would only be a factor if you are planning to sell the stock sometime this summer.
My reason's for thinking your $10.00 call is to low are as follows, the forecasted numbers for Q2 are quite impressive, more institutional investors are taking notice of what Quipt is accomplishing. I have always believed that one day the markets will give the company the proper trading valuation much closer to its peers.
We do not know where we are in the process for listing on the big board TSX, this could be announced sooner than later. Finally we know the company is still looking at more acquisitions in the future and albeit an outside shot the company could be acquired. I personally don't see us being bought out anytime soon, however Crawford and his team are really building a nice little company. You just never know who has Quipt in its scope. GLTA.